Evidence map›Paper›PMID 26956772›Full record

ArticleNature communications2016

Spacer-free BODIPY fluorogens in antimicrobial peptides for direct imaging of fungal infection in human tissue.

Lorena Mendive-Tapia, Can Zhao, Ahsan R Akram, Sara Preciado, Fernando Albericio, Martin Lee, Alan Serrels, Nicola Kielland, Nick D Read, Rodolfo Lavilla and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Lorena Mendive-TapiaInstitute for Research in Biomedicine, Barcelona Science Park, Baldiri Reixac 10-12, Barcelona 08028, Spain.
Can ZhaoManchester Fungal Infection Group, Institute of Inflammation and Repair, University of Manchester, CTF Building, Grafton St, Manchester M13 9NT, UK.
Ahsan R AkramMRC/UoE Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
Sara PreciadoInstitute for Research in Biomedicine, Barcelona Science Park, Baldiri Reixac 10-12, Barcelona 08028, Spain.
Fernando AlbericioInstitute for Research in Biomedicine, Barcelona Science Park, Baldiri Reixac 10-12, Barcelona 08028, Spain.
Martin LeeEdinburgh Cancer Research Centre, University of Edinburgh, Crewe South Road, Edinburgh EH4 2XR, UK.
Alan SerrelsEdinburgh Cancer Research Centre, University of Edinburgh, Crewe South Road, Edinburgh EH4 2XR, UK.
Nicola KiellandLaboratory of Organic Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona Science Park, Baldiri Reixac 10-12, Barcelona 08028, Spain.
Nick D ReadManchester Fungal Infection Group, Institute of Inflammation and Repair, University of Manchester, CTF Building, Grafton St, Manchester M13 9NT, UK.
Rodolfo LavillaCIBER-BBN, Networking Centre for Bioengineering, Biomaterials and Nanomedicine, Baldiri Reixac 10-12, Barcelona 08028, Spain.
Marc VendrellMRC/UoE Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
Centre for Inflammation Research · GBEdinburgh Cancer Research · GBInstitute for Research in Biomedicine · ESUniversitat de Barcelona · ESUniversity of Manchester · GBBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ES

Funding

Cancer Research UK C10195/A18075Cancer Research UK C157/A15703
6 · The paper itself

Abstract

Fluorescent antimicrobial peptides are promising structures for in situ, real-time imaging of fungal infection. Here we report a fluorogenic probe to image Aspergillus fumigatus directly in human pulmonary tissue. We have developed a fluorogenic Trp-BODIPY amino acid with a spacer-free C-C linkage between Trp and a BODIPY fluorogen, which shows remarkable fluorescence enhancement in hydrophobic microenvironments. The incorporation of our fluorogenic amino acid in short antimicrobial peptides does not impair their selectivity for fungal cells, and enables rapid and direct fungal imaging without any washing steps. We have optimized the stability of our probes in human samples to perform multi-photon imaging of A. fumigatus in ex vivo human tissue. The incorporation of our unique BODIPY fluorogen in biologically relevant peptides will accelerate the development of novel imaging probes with high sensitivity and specificity.

Indexed as

Antifungal AgentsAspergillosisAspergillus fumigatusBoron CompoundsDiagnostic ImagingFluorescent DyesHumansLungPeptides4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAntifungal AgentsBoron CompoundsFluorescent DyesPeptides

Identifiers

PMID26956772
PMCPMC4786873
OpenAlexW2296564964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.